Building a strong network for life science innovators
The Path to Pre-Clinical
Transitioning from R&D to Pre-Clinical Development
Program
At this in-person event, listen to lessons learned from experts and founders who have successfully gone through this phase of development and how to prepare for this critical milestone. Enjoy networking, heavy appetizers and refreshments after the panel. Free for entrepreneurs!
AGENDA:
- Registration: 4-4:30pm
- Panel Discussion: 4:30-5:30pm
- Networking and Refreshments with heavy appetizers: 5:30-7pm
Panel
So you’ve completed the proof-of-concept studies, and the data is in. Congratulations, your start-up is ready for the next major phase in the commercialization journey: pre-clinical development. This pivotal step in a biotech’s progression demands careful planning as the requirements and necessary expertise of the company are changing and expanding beyond what was needed during the initial development of your asset.
During this transition, the organization shifts from skill sets needed for discovery (such as proof-of-concept studies and early-stage development) to specialized knowledge and proficiency in managing compliance, understanding regulatory standards, creating reproducible studies and preparing documentation for regulatory submission.
